The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
astrazeneca | 12136 |
amylin pharmaceuticals | 577 |
astrazeneca uk | 455 |
medimmune | 359 |
array biopharma | 252 |
bristol-myers squibb company | 235 |
dainippon sumitomo pharma company | 217 |
nycomed | 177 |
bayer schering pharma | 147 |
almirall | 106 |
astrazeneca | 522 |
cancer research technology | 44 |
medimmune | 28 |
astrazeneca uk | 18 |
entasis therapeutics | 11 |
amylin pharmaceuticals | 10 |
ardea biosciences | 9 |
biowa | 9 |
kudos pharmaceuticals | 9 |
eolas therapeutics | 7 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
compuestos de 2-(2,4,5-anilino sustituido)pirimidina | 112 | 2011 |
n3 alkylated benzimidazole derivatives as mek inhibitors | 98 | 2002 |
phenyl or pyridinyl substituted indazoles derivatives | 80 | 2008 |
crystalline solvates and complexes of (1s)-1,5-anhydro-1-c-(3-((phenyl)methyl)phenyl)-d-… 🛈 | 73 | 2006 |
compounds and their use as bace inhibitors | 70 | 2010 |
heterocyclic inhibitors of mek and methods of use thereof | 70 | 2005 |
chemical process | 61 | 2005 |
camsylate salt | 60 | 2012 |
methods of reducing eosinophil levels | 58 | 2007 |
chromenone derivatives with anti-tumour activity | 58 | 2009 |